Target intelligence / Profile preview

Bacterial or Fungal Cell Membrane Protein

Molecular classification
Integral membrane protein, Peripheral membrane protein, Lipid-anchored protein, β-barrel outer membrane protein, Transporter, Enzyme, Structural protein, Receptor (rare in prokaryotes; more prevalent in fungal systems)
01

Overview

The term “Bacterial/Fungal Cell Membranes and Proteins” is a highly generic designation referring collectively to the lipid bilayers and their associated proteins present in bacteria and fungi. These membranes are composed mainly of phospholipids, proteins (integral, peripheral, and lipid-anchored), and, in fungi, ergosterol. Membrane proteins mediate essential functions including molecular transport, cell wall biosynthesis, cell division, energy transduction, and interactions with host immunity. Both bacteria and fungi possess unique targets in their membranes and associated proteins that distinguish them from mammalian cells, making them primary sites of action for antibiotics (such as β-lactams and glycopeptides) and antifungals (such as azoles and echinocandins). Notable targets include penicillin-binding proteins in bacteria, β-barrel outer membrane proteins in Gram-negative bacteria, and β-1,3-glucan synthase in fungi. Safety concerns for membrane-targeting drugs include host toxicity and the potential for resistance development. Due to the vast diversity in protein and lipid composition among species and the lack of a single, specific molecular target, this term is not a canonical or standardized therapeutic target designation, and should be avoided in favor of specifying particular membrane proteins or enzymes of interest. Note: - The target name is overly broad and does not map to a unique molecule or standardized therapeutic target form. Precise drug targeting and scientific reporting require specific identification (e.g., “Penicillin-binding protein 2a,” “β-1,3-glucan synthase”) rather than generic references to entire membranes or their protein complements. - As such, is_incorrect: true, since the target comprises many distinct molecules with highly variable functions and roles in therapy, rather than a specific, actionable entity.

Other names
bacterial cell membranesfungal cell membranesbacterial membrane proteinsfungal membrane proteinsbacterial/fungal cell membrane proteins
02

Mechanism of action

Inhibition of cell wall synthesis (e.g., PBPs, SEDS proteins, glucan synthases) Disruption of membrane integrity and permeability (e.g., polymyxins disrupt LPS in Gram-negatives, daptomycin disrupts membrane potential) Inhibition of ergosterol synthesis (in fungi; azoles) Inhibition of peptidoglycan crosslinking (β-lactams) Inhibition of β-glucan synthesis (echinocandins)

03

Biological functions

Cell structure integrityBarrier and transport of moleculesCell divisionCell wall biosynthesisEnergy metabolismImmune system interactionVirulence and pathogenicityBiofilm formation
04

Disease associations

InfectionAntimicrobial resistanceImmune evasionDrug target in antifungal/bacterial therapy
05

Safety considerations

Host toxicity due to non-selective membrane binding (e.g., nephrotoxicity with polymyxins)Resistance development (e.g., altered PBPs, β-lactamase production, membrane modification)Cross reactivity with human cell membranes in some drug classesImmunopathology due to cell wall component release
06

Interacting drugs

β-lactam antibiotics (e.g., penicillins, cephalosporins – targeting penicillin-binding proteins/PBPs)

5 more in the full profile.

07

Biomarkers

β-D-glucan (for systemic fungal infection)Chitin fragmentsFungal mannanOuter membrane protein antigens (for bacterial infections)

Beyond the preview

Go deeper on Bacterial or Fungal Cell Membrane Protein.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial or Fungal Cell Membrane Protein.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call